Use App
  • Trending
  • News
  • Earnings
DIADIA0.33%
SPYSPY0.15%
QQQQQQ0.06%
Trending
Top trending tickerBTCBTC4.18%
METAMETA4.95%
MSTRMSTR7.09%
GOOGLGOOGL2.46%
HPEHPE38.10%
PSKYPSKY0.94%
ETHETH1.09%
CRDOCRDO14.82%
MSFTMSFT0.17%
AVGOAVGO6.11%
Top trending tickerBTCBTC4.18%
METAMETA4.95%
MSTRMSTR7.09%
GOOGLGOOGL2.46%
HPEHPE38.10%
PSKYPSKY0.94%
ETHETH1.09%
CRDOCRDO14.82%
MSFTMSFT0.17%
AVGOAVGO6.11%
SVRA logo

SVRASavara Inc

$5.24
$0.05
(0.96%)
Today
·Closed $5.15
$0.09
(1.75%)
After Hours
Updated: 05:22 PM EDT
Loading...

Fundamentals

Mkt Cap
$1.07B
Volume
-
52W High
$7.01
52W Low
$1.98
PE Ratio
-9.22
Avg. Volume
1.28M
EPS (Annual)
-$0.5344
P/B
6.00
Rev/Employee
$0.00
Earnings
May 12

Feed

News

Sentiment

Earnings

Fundamentals

Info

Advertisement|Remove ads.

Latest SVRA News

View
Savara Announces Participation in the 2026 Jefferies Global Healthcare Conference
Business Wire
News Placeholder
Savara Presented New Biomarker Data from the IMPALA-2 Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2026
Business Wire
News Placeholder
Savara Presented Long-Term Efficacy and Safety Data from the Ongoing IMPALA-2 Phase 3 Clinical Trial Open-Label (OL) Extension of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Business Wire
News Placeholder
Top Discussions
Loading...

Advertisement|Remove ads.

TrendingNews
CommunityProfile